Formulations driving drug export growth: Pharmexcil chairman Namit Joshi
[ad_1] India’s pharmaceutical exports are poised to scale a new high of $32 billion despite sluggish growth in the US market and intense global scrutiny over quality. Speaking to Teena Thacker, Namit Joshi, chairman, Pharmaceuticals Export Promotion Council of India (Pharmexcil) said the country is well-placed not just to reach the $30-billion exports milestone again…